Compound (formerly Metamorphic Ventures) is a New York-based, thesis-driven, research-centric venture capital firm that invests in bleeding-edge technology being built by outliers, with a focus on AI/ML, robotics, computational biology, and crypto. The firm primarily leads seed and Series A rounds.
Their most common stage is seed (44% of deals). Average disclosed round size is $15.3M (across 53 rounds with reported amounts).
Portfolio
47
Fund Size
$73M
Top Stage
Seed
Last 12 Mo
2
Team
David Hirsch
General Partner
Celeste Holz-Schietinger
Venture Partner - Biology
Drew Gray
Venture Partner - AI & Robotics
Jason Kelly
Venture Partner - Biology & Healthcare
John Palmer
Venture Partner - Crypto
Ron Boger
Venture Partner - Computational Biology
Shelby Newsad
Partner
Mackenzie Morehead
Researcher
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Orbital | Series B | $50M | Jan 2026 |
 SyntheticFi | Seed | $13M | Jan 2026 |
 aifleet | Series B | $17M | Sep 2024 |
 Prime Intellect | Seed | $5.5M | Apr 2024 |
| BBriefly Bio | Pre-Seed | $1.2M | Jan 2024 |
| aifleet | Series B | $16.6M | Jan 2024 |
 Pear Bio | Series A | $14M | May 2023 |
 ONWARD | Series A | $9.7M | Oct 2022 |
 Nowsta | Series B | $41M | Jan 2022 |
 Wayve | Series B | $200M | Jan 2022 |
 Donut | Seed | $2M | Jun 2021 |
 Ease (company) | Series C | $41M | Mar 2021 |
 Tia | Series B | $24.3M | May 2020 |
 Talkspace | Series D | $50M | May 2019 |
 BetterView | Series A | $4.5M | May 2019 |
 Betterview | Series A | $4.5M | May 2019 |
 Compound | Seed | $8.2M | May 2018 |
 Orchid Labs | Series B | $36.1M | Apr 2018 |
| Talkspace | Series C | $31M | Sep 2017 |
| EEaseCentral | Series A | $6.5M | Jun 2017 |
 Stacks | Seed | $4M | Jan 2017 |
| BetterView | Unknown | $2M | Jan 2017 |
 Blockstack | Seed | $4M | Jan 2017 |
| Talkspace | Series B | $15M | Jun 2016 |
 PayJoy | Seed | $2.3M | Dec 2015 |
Top Co-Investors
Last updated: 7 September 2026